It is well-known that serum components destabilize liposomal membranes. Therefore, most in-vitro transfection protocols avoid serum, which make the extrapolation to in-vivo situations difficult. In this study, we investigated the stability of different anionic liposomal formulations including artificial viral envelopes (AVEs) in 100% fetal calf serum (FCS), human serum (HS) and human plasma (HP) by measuring the release of entrapped carboxyfluorescein (CF). We observed that FCS and HP induce leakage of CF from vesicles, while HS did not induce a pronounced leakage from the liposomes. In addition, we studied the effect of the phosphatidylethanolamine (PE) moiety, negatively charged lipid components and cholesterol (CHOL) on the stability of AVE liposomes. We found that the liposomes composed of DMPE/DPPG/CHOL (1:2:1) were the most stable liposomes in FCS and HP, among the examined liposomal formulations. Liposomes having a lipid composition similar to viral envelopes (AVE) were more stable in serum than pH-sensitive liposomes also used in gene therapy.
INTRODUCTION
Liposomes and lipid-based drug delivery systems have been used extensively over the last decade to improve the pharmacological and therapeutic activity of a wide variety of drugs. More recently, this class of carrier system has been used for the delivery of relatively large DNA and RNA-based drugs, including plasmids, antisense oligonucleotides and ribozymes. Non viral, lipid-based vectors have attracted particular attention in the field of gene therapy for a number of reasons, including safety, lack of antigenicity, versatility, and ease of handling (Lasic, 1993 (Lasic, , 1997 . Most of the cationic lipids used for gene transfer experiments drastically lose their efficiency in the presence of serum. Mady et al. (2004) have designed anionic liposomes, named artificial viral envelopes (AVEs), based on the composition of anionic retroviral envelopes (Chander and Schreier, 1992) , which display good transfection efficiency for cultured cells in the presence of serum. These AVE-liposomes have special fusogenic properties, allowing them to transport encapsulated or associated drugs into cells. Also, AVEliposomes effectively transport protamine-complexedoligonucleotides into HepG2 cells (Mady, 2007) . *Corresponding author. E-mail: dr_mmady@yahoo.com, mmady@ksu.edu.sa. Tel: +966-1-4698600.
Liposomal gene delivery system with a net negative surface potential should exhibit less nonspecific tissue uptake and a better overall biocompatibility than cationic carrier systems (Roerdink et al., 1983) . It is required to make at first a condensation of DNA with polycations, like protamine sulfate or polyethylenimine, before its loading into anionic liposomes. However, the potential use of non viral vectors as gene carriers by intravenous injection is limited by their low stability in bloodstream. Therefore, most in-vitro transfection protocols avoid serum, which make the extrapolation to in-vivo situations difficult. The stability of liposomes in the presence of serum can be thought as a first approximation to gain insight into the behavior of liposomes in biological fluids. A number of reports describe that the transfer of lipids from liposomes to high-density lipoproteins (HDL), which represents the major factor responsible for the disruptive effect of serum on the integrity of liposome bilayer (Damen et al., 1981; Allen, 1981) . The process of this lipid transfer seems to be mediated by apolipoproteins.
Insertion of apolipoproteins into the membrane of small unilamellar vesicles at conditions near the phase-transition temperature of the lipids may cause an accelerated leakage of the entrapped contents (Weinstein et al., 1981; . Moreover, liposomes are eliminated from circulation by association with certain plasma proteins, called opsonins, which promote macrophage uptake, or by direct adsorption to the cell surface and ultimate phagocytosis by macrophages in liver and spleen (Moghimi and Patel, 1989) .
The complement system is considered to be the first line of self-defense in the body against foreign colloidal matter. Activated complement components also induce liposome leakage by forming pores in the liposome membrane (Liu and Huang, 1990) . It eliminates foreign particles by the reticuloendothelial system (RES) as opsonins and by forming a membrane attack complex (MAC) to lyse them (Morgan, 1990) . So, one of the crucial aspects of using liposomes as a drug (gene) delivery vehicles is to understand their interaction with plasma or serum components.
Previous works with our group show that AVE can be targeted efficiently for gene delivery in serum into human cancer cells (Mady, 2007; Mady et al., 2004 Mady et al., , 2009 . In the present work, we have quantified the disruptive effects of FCS, HS, and HP on the AVE-liposomes and have studied whether modifications (phosphatidylethanolamine (PE), negatively charged lipid, and cholesterol content) in their phospholipid composition might produce liposomes with an increased carrier potential for application in vivo. Furthermore, we compared the stability of AVE liposomes and pH-sensitive liposomes in 100% FCS. Liposomes composed of CHEMS/DOPE (3:2) were chosen for this comparison, because they were found to be more stable (pH-sensitive liposome composition) in serum (Shepushkin et al., 1997) .
MATERIALS AND METHODS
1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol, (DPPG) was purchased from (Sygena Ltd, Switzerland), L-α-dipalmitoyl phosphatidic acid (DPPA), 1,2-dilauroyl-sn-glycero-3-phosphoethanolamine (DLPE), dioleoyl phosphatidyl serine (DOPS), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) and 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine (DMPE) were obtained from Avanti Polar-Lipids Inc. (Ottawa, Canada), cholesteryl hemisuccinate (CHEMS) was purchased from Sigma (MO, USA). Tris ultra pure buffer and sodium deoxycholate were obtained from ICN Biomedicals Inc. (Ohio, USA). 4(5)-carboxyfluorescein (CF) was purchased from Fluka (Germany). All reagents were of analytical reagent grade. Fresh human serum and plasma obtained from a healthy male member in our group. Fetal calf serum (FCS) was obtained from Bio Whittaker Europe, Cambrex Company, (Belgium).
Preparation of liposomes
AVE-liposomes are composed of equimolar amounts of DLPE, DOPS and CHOL (Mady et al., 2004) . Liposomes were formulated according to the well-established method of extrusion (Olson et al., 1979) . In short, the appropriate phospholipid composition was mixed in organic solvent (chloroform) in a 50 ml round flask. The organic solvent was evaporated to dryness by a Mini-Rotavapor (Büchi, Switzerland). The resulting thin lipid film was hydrated with tris buffered saline (10 mM, 140 mM NaCl) containing 100 mM CF at pH 7.4. The resulting lipid suspension was extruded through 200 nm nucleopore membranes (Nucleopore GmbH, Germany), using a GmbH, Germany) in Tris buffered saline containing 10 mM Tris and 140 mM NaCl at pH 7.4 after extrusion (Yamada et al., 1998) .
Liposomal stability assay
Liposomal stability is defined as its capability to retain the structural integrity of the lipid bilayer and prevent leakage of their aqueous contents (Lelkes and Tandeter, 1982) . The release experiments were run immediately after the separation of free CF from encapsulated CF in liposomes. The liposomes were incubated with 100% FCS, human serum or human plasma at 37°C (lipid/serum ratio of 0.33 mg/ml). At indicated time points, 10 µl of the suspension were diluted 200 times with Tris buffered saline and the fluorescence intensity (F; excitation at 470 nm, emission at 520 nm) was measured on a Perkin Elmer Spectrofluorometer LS 50B (U.K.). To lyse liposomes completely, 20 µl of 10% sodium deoxycholate was added and the total fluorescence Ftotal (corresponding to 100% release) was measured. The percentage of CF release was calculated by dividing F by Ftotal. A plot of % CF release versus time was linear until approximate 20 to 30% CF remained trapped in liposomes, indicating that the initial 70 to 80% of leakage is a single exponential process. Estimates of half-time, t½, (time at which 50% of CF is still encapsulated) was determined from the initial linear portion of the curve (Allen and Cleland, 1980) ).
RESULTS

Serum-induced leakage of liposomal contents
It is accepted that some of serum components play important roles in enhancing liposome permeability and in facilitating rapid liposome uptake by the mononuclear phagocytic system (Liu et al., 1997) . Comparison between AVE-liposomes incubated with 100% FCS or Tris buffered saline at 37°C showed that serum promotes CF release from liposomes. In the absence of serum components, dye escaped very slowly from liposomes without apparent change in liposomal structure. The t½ were 17 h and 111.5 h for DLPE/DOPS/CHOL (1:1:1) liposomes in 100% FCS and Tris buffered saline, respectively ( Figure 1 and Table 1 ). These results agree with previous data (Damen et al., 1981; Allen, 1981 ) and might be due to the transfer of lipids from liposomes to high-density lipoproteins (HDL), which is a major factor responsible for the disruptive effect of serum on the integrity of liposome bilayer. The process of this lipid transfer seems to be mediated by apolipoproteins (Weinstein et al., 1981 . Activated complement components also induce liposome leakage by forming pores in the liposomal membrane (Liu and Huang, 1990) . However, when AVE liposomes were incubated with fresh human serum (data not shown), there was no marked release of CF [< 40% after 150 h for DLPE/DOPS/CHOL (1:1:1)] indicating that 100% FCS contains certain serum components responsible for the destabilization of liposomes while human serum is not containing these components. These results are in good agreement with those described elsewhere (Lelkes and Freidmann, 1984; Liu et al., 1997) .
Human plasma induced leakage of liposomal contents
When AVE liposomes were incubated in fresh human plasma at 37°C, a faster leakage of CF from liposomes was observed (Figure 2 ). The t½ were 9.93, 5.46, 3.75 and 0.255 h for DMPE/DPPG/CHOL (1:2:1), DLPE/DOPS/CHOL (1:1:1), DLPE/DPPG/CHOL (1:2:1) and DLPE/DOPS (1:1), respectively (Table 1) . Massive release of CF from liposomes during incubation with human plasma suggests that the lipid transfer from liposomes to HDL has a highly destructive influence on the liposomal structure (Scherphof et al., 1979) . Induced release of CF from liposomes by apolipoproteins was usually associated with rapid formation of discs although other structures were sometimes formed as evident by electron microscopy study (Guo et al., 1980) . Also, the plasma-induced dissolution of unsonicated liposomes is most probably achieved by the interaction with (apo) lipoproteins (Scherphof et al., 1979) . Human plasma fibronectin, a membrane-associated protein involved in cell-cell adhesion and growth control, binds tightly to phospholipid vesicles of various compositions, as shown by density gradient centrifugation. The binding results in extensive aggregation of the vesicles (Rossi and Wallace, 1983) . The interaction between vesicles and plasma may result in the formation of pores through which encapsulated solutes diffuse at dependent rates (Kirby and Gregoriadis, 1981; Yoshioka et al., 1985) .
Heat inactivated FCS
Heating FCS at 56°C for 30 min markedly decreased the leakage rate of CF from liposomes. When the liposomes were incubated with heat inactivated FCS at 37°C (Figure  3 ), the t½ were 35.67 and 85.35 h for DLPE/DPPG/CHOL
(1:2:1) incubated with fresh FCS and heat inactivated FCS, respectively. Also, the t½ were 0.84 and 5.36 h for DLPE/DOPS (1:1) incubated with fresh FCS and heat inactivated FCS, respectively (Table 1 ). The results suggest that the mechanism of liposomes lysis is due to complement activation via the alternative pathway rather than via the classical pathway (Liu et al., 1997) .
Effect of phosphoethanolamine moiety
It is evident from Figure 4 and Table 1 that DMPE containing liposomes were more stable than those containing DLPE or DOPE. The t½ in 100% FCS were 21.06, 17 and 8.8 h for DMPE, DLPE and DOPE containing liposomes, respectively. It is also true in Figure 2 that DMPE containing liposomes were more stable than DLPE containing liposomes in HP as well as FCS (Figure 2 ). These findings may be due to shorter fatty acid chains of DLPE than those of DMPE, which may therefore be extractable more easily from the liposomal membrane. Also, DOPE contains a relatively small and weakly hydratable head group and two cisunsaturated, bulky acyl chains (Cullis and de Kruijff, 1979) .
Effect of negatively charged lipids
The DPPG containing liposomes were more stable than those containing DOPS or DPPA. The t½ in 100% FCS were 35.67, 17 and 6.36 h and for DLPE/DPPG/CHOL (1:2:1), DLPE/DOPS/CHOL (1:1:1) and DLPE/DPPA/CHOL (1:2:1), respectively ( Figure 5 , Table 1 ). Also, DPPG increases the t½ of the DMPE containing liposomes. The t½ in 100% FCS were 56.35, 21.15 and 21.06 h for DMPE/DPPG/CHOL (1:2:1), DMPE/DPPA/CHOL (1:2:1) and DMPE/DOPS/CHOL (1:1:1), respectively (Table 1) . These findings may be due to the fact, that DOPS accelerates the rate of liposome interaction with HDL (Bienvenue et al., 1985) and DOPS containing liposomes are more fusogenic than that containing DPPG. Furthermore, DPPG is a lipid with high phase transition temperature and can increase the rigidity of the bilayer, which inhibits the penetration of serum proteins and lipoproteins (by their hydrophobic side chains) into the lipid bilayer (Gabizon and Papahadjopoulos, 1992) . We found that DLPE/DPPG/CHOL liposomes are more stable in FCS than DLPE/DOPS/CHOL liposomes ( Figure  2 and Table 1 ). However, in HP, DLPE/DOPS/CHOL liposomes are more stable than DLPE/DPPG/CHOL liposomes. This may be due to the variability between FCS and HP. A certain difference either in the amount of active serum components or in the biological activity based on a "species" genetic characteristics (Liu et al., 1997) . Figure 6 shows that the presence of cholesterol in liposomes decreases the liposome leakage and consequently increases their half-life time. The t½ in 100% FCS were 17 and 0.84 h for DLPE/DOPS/CHOL (1:1:1), DLPE/DOPS (1:1), respectively. It is known, that cholesterol inhibits the phospholipid exchange of liposomes with HDL (Chobanian et al., 1979; Jonas and Maine, 1979) and association with serum proteins, which facilitates the uptake of liposomes by the reticuloendothelial system (RES) (Allen and Chonn, 1987; Allen et al., 1989) .
Effect of cholesterol
Stability of pH-sensitive liposomes
We compared the stability of DLPE/DOPS/CHOL (1:1:1) with pH-sensitive liposomes (DOPE/CHEMS (3:2)) in FCS. pH-sensitive liposomes have been shown to mediate gene transfer (Wang and Huang, 1987; Shepushkin et al., 1997) ) but they suffer from their rapid removal from circulation in vivo. Incubation of DOPE/CHEMS (3:2) liposomes with 100% FCS shows a small t½ of 0.767 h (Figure 7 and Table 1) which agrees with that investigated early (Shepushkin et al., 1997) . Previously, Connor et al. (1986) showed that pH-sensitive liposomes are very leaky in the presence of serum probably due to their interactions with serum components.
The HDL inserts into the liposomes causing an exchange of lipid component and destabilizing the liposomes, which induces leakage and subsequent aggregation. It is possible that the serum components partially or completely remove the CHEMS constituent of the liposome system. This would cause the DOPE to revert to the hexagonal phase and aggregate. These results indicate that AVE liposomes are more stable than pH-sensitive liposomes.
DISCUSSION
Because of the fast progress of nucleic acid-based technologies in the treatment of diseases, the call for appropriate delivery vehicles becomes increasingly important. One of the problems confronting researchers who wish to use liposomes in the treatment of disease is the rapid removal of liposomes in vivo. The ideal vehicle should avoid immediate uptake by the mononuclear phagocyte system and have prolonged circulation in blood, thus increasing the probability of reaching the desired targets. In addition, the vehicle should be able to deliver its contents efficiently into the cell cytoplasm, avoiding lysosomal degradation. Recently, AVE liposomes have been used successfully to deliver oligonucleotides and DNA into a variety of cells in vitro. The present experiments were designed to look at the contents leakage from a variety of AVE vesicles in the presence of undiluted FCS, human serum and plasma at 37°C. These conditions approximate in vivo conditions making this system an appropriate in vitro model for predicting liposome permeability in vivo. To optimize the potential of AVE liposomes as drug and/or gene carriers, it is important to characterize their stability in terms of controlled release of their contents in vitro, simulating physiological conditions in vivo.
Several observations in the present study confirm former results from observations on conventional liposomes for example, the higher liposomal stability at higher cholesterol content (Kirby et al., 1980) . There are biological reasons for the lower stability of some AVE liposome compositions compared to the stability of conventional liposomes. These reasons include for example, that viral envelopes, which were the basis for the development of AVE, are more prone to be attacked by complement system, because the body may have been exposed earlier to this type of viral membranes. One of the lipid components of AVE is a negatively charged lipid, and it is known that negatively charged liposomes bind to and are endocytosed by cells to a greater extent than neutral liposomes (Fraley et al., 1981; Heath et al., 1985) . For example, phosphatidyl serinecontaining liposomes are taken up by scavenger receptors (Kamps et al., 1999) . Many conventional liposomal formulations contain DPPC or DPPG, a lipid with high phase transition temperature and thereby increase the rigidity of the bilayer, which inhibits the penetration of serum proteins and lipoproteins into the lipid bilayer. We could also demonstrate this effect by exchanging DOPS by DPPG in the AVE formulations. Incubation of AVE formulations in serum-containing medium showed therefore a reduction of their half life times.
As demonstrated, the t ½ of the DMPE/DPPG/CHOL (1:2:1) or DLPE/DOPS/CHOL (1:1:1) were 56.35 and 17 h, respectively in 100% FCS and 9.93 and 5.46 h, respectively in human plasma. We found that DMPE/DPPG/CHOL (1:2:1) liposomal formulation is the most stable formulation in FCS and HP among the examined liposomal formulations. According to the results, AVE liposomes are more stable than pHsensitive liposomes that were found to be able to mediate a target-specific delivery of plasmid DNA to lymphoma cells grown in a nude mouse model (Wang and Huang, 1987) . The results indicate that the use of liposomes as gene/drug delivery system in the treatment of patients must take into account HDL fluctuations in their blood as these could alter liposomal membrane permeability to the drugs and thus upset therapeutic efficiency. In conclusion, these t ½ values of AVE liposomes may be sufficient for the targeting of these liposomes to special cell types using receptor-sensitive ligands thereby enhancing localized uptake of drugs into cells of interest, especially if one considers the rapid blood circulation in mammals.
